Right Heart Failure clinical trials

Explore recruiting right heart failure clinical trials.

Recruiting right heart failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Right Heart Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Dapagliflozin in patients with Right Heart Failure (Dapa-RHF)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF COR-1389

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

(15681) Open-label, individual dose titration study to evaluate safety, tolerability and pharmacokinetics of riociguat in children from 6 to less than 18 years of age with pulmonary arterial hypertension (PAH)

Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension

Austria, Belgium, Denmark, Germany, Spain, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

Greece, France, Italy, Belgium, Denmark, Germany +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Right Heart Failure trials by city

Right Heart Failure in Toronto Right Heart Failure in Vancouver Right Heart Failure in Montreal Right Heart Failure in Calgary Right Heart Failure in Edmonton Right Heart Failure in Ottawa Right Heart Failure in Winnipeg Right Heart Failure in Quebec City Right Heart Failure in Hamilton Right Heart Failure in Kitchener Right Heart Failure in London Right Heart Failure in Halifax Right Heart Failure in New York Right Heart Failure in Los Angeles Right Heart Failure in Chicago Right Heart Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease